This year’s Annual Review ‘Creating the future in sight’ reflects on the past 30 years of CERA’s research, while looking forward to the treatments within reach that will protect vision for more people than ever before.
CERA’s newest spin out company Adara Bio is forging key partnerships to support its work to develop precision treatments for blindness caused by inherited retinal disease (IRD).
New research has found artificial intelligence can check for diseases like diabetes, osteoporosis and thyroid disease in seconds with a simple snap of the eye, transforming how people could be diagnosed.
A CERA researcher has won a Premier’s Award for Health and Medical Research for her work investigating the impact of artificial intelligence screening tools to detect people at risk of irreversible vision loss from glaucoma.
